News
BioGenes Berlin

We’ve officially launched our Recombinant Antibody Services!

Our platform enables a seamless transition from hybridoma to recombinant formats, combining high reproducibility, long-term stability and precise antibody engineering (isotype switching, chimerization).

The result? Sequence-defined antibodies with improved performance and traceability.

And don't miss out on our launch offer: the first 10 projects receive a free hybridoma sequencing! A great opportunity to future-proof your antibodies at no additional cost.
Get in touch to discuss your project at service@biogenes.de.